Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP8 | P22894 | 1/20 | 0.53 |
| ▸ | PKM | P14618 | 3/20 | 0.41 |
| ▸ | CYP4F2 | P78329 | 3/20 | 0.36 |
| ▸ | CYP4A11 | Q02928 | 3/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.33 |
| ▸ | HTR2A | P28223 | 1/20 | 0.33 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.33 |
| ▸ | PPARA | Q07869 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10817059 | 0.85 | TSHR (0.42) | MMP8PKMALDH1A1TSHRTHRB | |
| SCHEMBL23295136 | 0.83 | ATM (0.42) | MMP8ALDH1A1CYP1A2TSHRLMNA | |
| SCHEMBL9014056 | 0.82 | MMP8 (0.41) | MMP8PKMALDH1A1TSHRHSD17B10 | |
| SCHEMBL335263 | 0.82 | MMP8 (0.42) | MMP8PKMCYP4F2CYP4A11ALDH1A1 | |
| SCHEMBL2555317 | 0.80 | PKM (0.46) | MMP8PKMCYP4F2CYP4A11ALDH1A1 | |
| SCHEMBL7857447 | 0.76 | MMP8 (0.59) | MMP8PKMCYP4F2CYP4A11ALDH1A1 | |
| SCHEMBL4426319 | 0.76 | MMP8 (0.76) | MMP8PKMCYP4F2CYP4A11ALDH1A1 | |
| SCHEMBL9040519 | 0.76 | PKM (0.48) | MMP8PKMCYP4F2CYP4A11ALDH1A1 | |
| SCHEMBL12574780 | 0.75 | MMP8 (0.58) | MMP8PKMCYP4F2CYP4A11ALDH1A1 | |
| SCHEMBL234014 | 0.74 | MMP8 (0.56) | MMP8PKMCYP4F2CYP4A11ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230265059-A1 | SOLID STATE FORMS OF 6-CARBOXY-2-(3, 5-DICHLOROPHENYL)-BENZOXAZOLE OF FORMULA-I AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | NURAY CHEMICALS PRIVATE LIMITED (IN) | 2023-08-24 | — | — | US | claimed |
| WO-2022009221-A1 | SOLID STATE FORMS OF 6-CARBOXY-2-(3, 5-DICHLOROPHENYL)-BENZOXAZOLE OF FORMULA-I AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | NURAY CHEMICALS PRIVATE LIMITED (IN) | 2022-01-13 | — | — | WO | claimed |
| US-9120755-B2 | Polymorphic forms of ivabradine hydrochloride | CADILA HEALTHCARE LIMITED (IN) | 2015-09-01 | — | — | US | claimed |
| US-20230265059-A1 | SOLID STATE FORMS OF 6-CARBOXY-2-(3, 5-DICHLOROPHENYL)-BENZOXAZOLE OF FORMULA-I AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | NURAY CHEMICALS PRIVATE LIMITED (IN) | 2023-08-24 | — | — | US | disclosed |
| WO-2022009221-A1 | SOLID STATE FORMS OF 6-CARBOXY-2-(3, 5-DICHLOROPHENYL)-BENZOXAZOLE OF FORMULA-I AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | NURAY CHEMICALS PRIVATE LIMITED (IN) | 2022-01-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230265059-A1 | SOLID STATE FORMS OF 6-CARBOXY-2-(3, 5-DICHLOROPHENYL)-BENZOXAZOLE OF FORMULA-I AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | CYP2D6, CYP3A7, CYP2B6 | MMP8 4434/4885PKM 641/4885CYP4F2 16/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.